Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.36B | 1.42B | 1.44B | 1.31B | 1.23B |
Gross Profit | 359.89M | 372.63M | 335.27M | 274.16M | 275.69M |
EBITDA | 166.80M | 178.83M | 179.34M | 80.05M | 90.75M |
Net Income | 85.05M | 99.61M | 104.11M | 3.49M | 15.44M |
Balance Sheet | |||||
Total Assets | 1.18B | 884.06M | 915.37M | 887.86M | 1.02B |
Cash, Cash Equivalents and Short-Term Investments | 41.45M | 37.22M | 19.92M | 37.58M | 47.28M |
Total Debt | 351.92M | 106.19M | 181.64M | 163.00M | 165.00M |
Total Liabilities | 687.37M | 413.04M | 518.96M | 501.66M | 522.35M |
Stockholders Equity | 487.90M | 471.02M | 396.41M | 386.20M | 492.75M |
Cash Flow | |||||
Free Cash Flow | 89.57M | 160.97M | 57.52M | 78.63M | 115.70M |
Operating Cash Flow | 125.16M | 204.15M | 102.70M | 100.47M | 141.86M |
Investing Cash Flow | -265.89M | -43.67M | -27.71M | 9.28M | -2.15M |
Financing Cash Flow | 146.05M | -144.61M | -91.02M | -120.57M | -107.88M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $1.88B | 14.61 | 13.70% | ― | -5.13% | 16.93% | |
77 Outperform | $1.27B | 25.47 | 9.51% | ― | -13.95% | -63.37% | |
73 Outperform | $946.01M | 18.75 | 10.68% | 2.39% | -0.77% | -52.02% | |
68 Neutral | $694.40M | 18.68 | 5.96% | ― | -4.22% | -16.01% | |
62 Neutral | $932.34M | 34.16 | 2.18% | 1.58% | 47.66% | -75.65% | |
62 Neutral | C$6.75B | 7.69 | 3.45% | 2.75% | 6.63% | -23.02% | |
45 Neutral | $392.38M | ― | -55.39% | ― | -14.12% | -1264.86% |
On June 25, 2025, Apogee held its Annual Meeting of Shareholders where three key proposals were voted upon. The re-election of two Class III directors, Elizabeth M. Lilly and Mark A. Pompa, was confirmed for three-year terms. Additionally, the shareholders approved the company’s executive compensation and ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending February 28, 2026.
The most recent analyst rating on (APOG) stock is a Buy with a $48.00 price target. To see the full list of analyst forecasts on Apogee stock, see the APOG Stock Forecast page.